Alaleh Nouri - 03 Mar 2025 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role: EVP, CLO, CORP. SEC.
Signature: /s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri
Issuer symbol: PRCT
Transactions as of: 03 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2025, 17:36:04 UTC
Previous filing: 06 Dec 2024
Next filing: 10 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRCT	Common Stock	Award	$0	+12,958	+25%	$0.000000	65,430	03 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRCT	Stock Option (Right to Buy)	Award	$0	+11,445		$0.000000	11,445	03 Mar 2025	Common Stock	11,445	$60.60	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.
F2	1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.